Cargando…
Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253538/ https://www.ncbi.nlm.nih.gov/pubmed/34224667 http://dx.doi.org/10.1016/S2352-3026(21)00199-X |
_version_ | 1783717534544953344 |
---|---|
author | Lim, Sean H Campbell, Nicola Johnson, Marina Joseph-Pietras, Debora Collins, Graham P O'Callaghan, Ann Fox, Christopher P Ahearne, Matthew Johnson, Peter W M Goldblatt, David Davies, Andrew J |
author_facet | Lim, Sean H Campbell, Nicola Johnson, Marina Joseph-Pietras, Debora Collins, Graham P O'Callaghan, Ann Fox, Christopher P Ahearne, Matthew Johnson, Peter W M Goldblatt, David Davies, Andrew J |
author_sort | Lim, Sean H |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8253538 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82535382021-07-06 Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma Lim, Sean H Campbell, Nicola Johnson, Marina Joseph-Pietras, Debora Collins, Graham P O'Callaghan, Ann Fox, Christopher P Ahearne, Matthew Johnson, Peter W M Goldblatt, David Davies, Andrew J Lancet Haematol Comment Elsevier Ltd. 2021-08 2021-07-02 /pmc/articles/PMC8253538/ /pubmed/34224667 http://dx.doi.org/10.1016/S2352-3026(21)00199-X Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Comment Lim, Sean H Campbell, Nicola Johnson, Marina Joseph-Pietras, Debora Collins, Graham P O'Callaghan, Ann Fox, Christopher P Ahearne, Matthew Johnson, Peter W M Goldblatt, David Davies, Andrew J Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma |
title | Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma |
title_full | Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma |
title_fullStr | Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma |
title_full_unstemmed | Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma |
title_short | Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma |
title_sort | antibody responses after sars-cov-2 vaccination in patients with lymphoma |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253538/ https://www.ncbi.nlm.nih.gov/pubmed/34224667 http://dx.doi.org/10.1016/S2352-3026(21)00199-X |
work_keys_str_mv | AT limseanh antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma AT campbellnicola antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma AT johnsonmarina antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma AT josephpietrasdebora antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma AT collinsgrahamp antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma AT ocallaghanann antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma AT foxchristopherp antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma AT ahearnematthew antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma AT johnsonpeterwm antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma AT goldblattdavid antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma AT daviesandrewj antibodyresponsesaftersarscov2vaccinationinpatientswithlymphoma |